This is research, not a buy or sell recommendation. Robo-advice in Taiwan requires an FSC licence; FEAF analyses, explains and monitors, and the investor makes the decision. Judgement thresholds are working rules pending review by the team's finance members.
Plain-language summary of valuation, growth, profitability, balance sheet, and recent MOPS filings.
Mixed picture: 1 strengths against 2 watch-outs. Weigh them against your own goals.
Points to watch for a moderate profile: see the items marked above.
In plain words
In 2025, revenue for company 2022 grew 16.7%, while the latest Q3 2026 revenue grew 3.6% year on year. However, the company shows weak profitability with a return on equity of -3.0% and a net margin of -0.9%. Liabilities stood at 42.8% of total assets in Q3 2026, and free cash flow was negative at -860 NT$ million in 2025 as spending exceeded operating cash. Additionally, there are 4 verified alerts and 2 filings held or rejected waiting for human review. Ultimately, the financial picture is mixed, and final investment decisions rest entirely with the investor.
Written by gemini-3.6-flash from the facts above; every number was checked against them.
Strengths
+Revenue grew 16.7% in 2025; latest quarter Q3 2026: 3.6% year on year. source (Financials) →
Watch-outs
!Return on equity -3.0% with a -0.9% net margin: weak profitability. source (Key Stats) →
!Free cash flow was negative in 2025: -860 NT$ million, so spending exceeded operating cash. source (Financials) →
What to check before deciding
?What would lift profitability, and how soon?
?What is the spending for, and when does it start paying back?
What the analysis found
+GrowthRevenue grew 16.7% in 2025; latest quarter Q3 2026: 3.6% year on year. source →
!ProfitabilityReturn on equity -3.0% with a -0.9% net margin: weak profitability. source →
·DebtLiabilities are 42.8% of total assets (Q3 2026). source →
!Cash flowFree cash flow was negative in 2025: -860 NT$ million, so spending exceeded operating cash. source →
·Filings4 verified alert(s); latest on 2026-11-12: 公告本公司115年第3季合併財務報告 source →
·Filings2 filing(s) are held or rejected and wait for human review. source →